Maria Marketou

Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension

Joanna Kontaraki, Maria Marketou, Evangelos Zacharis et al. · Journal of Human Hypertension · 2013 · 111 citations

Hypertension, Molecular Physiology, Cardiovascular Disease +13

MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage

Joanna Kontaraki, Maria Marketou, Evangelos Zacharis et al. · Journal of the American Society of Hypertension · 2014 · 107 citations

Hypertension, Target-organ Damage, Cardiovascular Disease +11

Low-Dose Amiodarone Versus Sotalol for Suppression of Recurrent Symptomatic Atrial Fibrillation

George Kochiadakis, Nikos E. Igoumenidis, Maria Marketou et al. · The American Journal of Cardiology · 1998 · 83 citations

Cardiovascular Disease, Medicine, Cardiovascular Pharmacology +6

A Comparative Study of the Efficacy and Safety of Procainamide Versus Propafenone Versus Amiodarone for the Conversion of Recent-Onset Atrial Fibrillation

George Kochiadakis, Nikos E. Igoumenidis, Michail E. Hamilos et al. · The American Journal of Cardiology · 2007 · 58 citations · Full text

Thrombosis, Recent-onset Atrial Fibrillation, Cardiac Anaesthesia +11

Amiodarone, Sotalol, or Propafenone in Atrial Fibrillation: Which Is Preferred to Maintain Normal Sinus Rhythm?

George E. Kochiadakis, Maria Marketou, Nikos E. Igoumenidis et al. · Pacing and Clinical Electrophysiology · 2000 · 55 citations